Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cholesteryl ester transfer protein antagonism by drugs--a poor choice.

Clinical chemistry - 1 Oct 2010

Sirtori Cesare R, Mombelli Giuliana

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticholesteremic Agents
Share to Atorvastatin
Share to Cholesterol Ester Transfer Proteins
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Coronary Disease

Share to Heptanoic Acids

Share to Pyrroles

Share to Quinolines

Source

Identifiers

PMID: 20802095
DOI: 10.1373/clinchem.2010.147389

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cholesteryl ester transfer protein antagonism by drugs--a poor choice.PMID 20802095Read ↗

When good drugs go bad.Semantic proximity Read ↗

New drug fizzles at raising HDL. Tried-and-true strategies are still excellent ways to boost good cholesterol.Semantic proximity Read ↗

Therapeutic modulation of cellular cholesterol efflux.Semantic proximity Read ↗

Fitting the drug to the patient.Semantic proximity Read ↗

Future perspectives for the development of P-glycoprotein modulatorsSemantic proximity Read ↗

Antileukotriene therapy. Future directions.Semantic proximity Read ↗

PharmGKB summary: Efavirenz pathway, pharmacokinetics.Semantic proximity Read ↗

Are human CETP mutations and CETP-inhibiting drugs a good or a bad deal?Semantic proximity Read ↗

Intolerance to statins: mechanisms and management.Semantic proximity Read ↗

Cholesteryl ester transfer protein inhibition in cardiovascular risk management: ongoing trials will end the confusion.Semantic proximity Read ↗

Farnesyltransferase inhibitors versus Ras inhibitorsSemantic proximity Read ↗

Expanding the clinical utility of therapeutic proteins: activated protein C variants with improved pharmacological properties.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.